Table III.

Mono amino oxidase inhibitors (120).

Drug	Selectivity	FDA approval	Common adverse effects >10% incidence	Administration in pregnancy	Interactions
Isocarboxazide	Non-selective MAOIs	1959	Weight gain, chills orthostatic hypotension, forgetful, headache, sexual dysfunction, lethargy, constipation, dizziness, serotonin syndrome	No data	Salmeterol, trazodone, alcohol, citalopram, zolpidem, duloxetine, amitriptyline, venlafaxine, escitalopram, phenelzine and lisdexamfetamine.
Phenelzine		1961	Dizziness, confusion, chills, tremors, drowsiness, weakness, insomnia and dry mouth	No data	Citalopram, duloxetine, dextromethorphan, meperidine, fentanyl, tryptophan, lisdexamfetamine and vilazodone.
Selegiline		1998	Orthostasis, dizziness, nausea and abdominal pain	No	Duloxetine, escitalopram, meperidine, rasagiline, bupropion and amphetamine
Tranylcypromine	Selective MAO-A inhibitors	1961	Anxiety, dizziness, weakness and constipation.	No data	Duloxetine, citalopram, selegiline, phenelzine, escitalopram, paroxetine, pseudoephedrine and lisdexamfetamine.
Brofaromine		1995	Tremor, sleep disorders, dry mouth and hypotension	No data	Warfarin, amantadine, amitriptyline, apomorphine, benzodiazepine, bupropion, dobutamine, duloxetine and ethanol.

MAO, mono amino oxidase.